Slovenia - Lipid Modifying Medicine Use
Since 2014, Slovenia Lipid Modifying Medicine Use increased 4.8% year on year. At 142 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, the country was number 5 comparing other countries in Lipid Modifying Medicine Use. Slovenia is overtaken by Belgium, which was ranked number 4 with 145.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Canada at 141.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Denmark topped the ranking with 159.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, that is a growth of 3.5% versus 2018. Lithuania witnessed the best average annual growth at +18.8% per year, while Slovakia recorded the worst performance at -8.7% per year.
Loading...
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 142.00 |
| 2018 | 137.80 |
| 2017 | 132.70 |
| 2016 | 125.10 |
| 2015 | 118.30 |
How does Slovenia rank in Lipid Modifying Medicine Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Denmark
|
160 | 2019 | +3.5 % | +3.8 % | View data | |
| 2 |
#2
United Kingdom
|
153 | 2019 | +1.7 % | +2.3 % | View data | |
| 4 |
#4
Belgium
|
146 | 2019 | +2.6 % | +2.1 % | View data | |
| 5 |
#5
Slovenia
|
142 | 2019 | +3.0 % | +4.8 % | View data | |
| 6 |
#6
Canada
|
142 | 2019 | +8.8 % | +7.1 % | View data | |